Compared with gilteritinib, the same concentration of GNF-7 had a stronger inhibitory effect on leukemia cell proliferation in three FLT3-ITD AML patients (Additional file 1: Fig. S4A–C). Here, FLT3 is linked to acute myeloid leukemia.